The Net Margin of Beijing Konruns Pharmaceutical Co Ltd (603590.SS) is 18.14%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-12-31 | 18.14% |
| 2024-12-31 | 5.09% |
| 2023-12-31 | 16.35% |
| 2022-12-31 | 11.71% |
| 2021-12-31 | 18.27% |
| 2020-12-31 | 22.68% |
| 2019-12-31 | 24.96% |
| 2018-12-31 | 25.82% |
| 2017-12-31 | 81.07% |
| 2016-12-31 | 55.37% |